Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Aug 2026 for Allogene Therapeutics, Inc., €54k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Douglas Earl Martin: trading record in brief
One trade, one date: on 21 August 2026, Douglas Earl Martin disclosed a transaction of €54k in Allogene Therapeutics, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Douglas Earl Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
29,697 shares@ US$2.12Common StockSEC144:0001737287-26-000023
1 of 1 declaration
